How Genprex took an abandoned pipeline drug and turned it into Oncoprex, an innovative treatment for non-small cell lung cancer October 17, 2018Kalyn DabbsMedia Coverage original article: How Genprex took an abandoned pipeline drug and turned it into Oncoprex, an innovative treatment for non-small cell lung cancer | NASDAQ:GNPX (proactiveinvestors.com)